ea0019p337 | Steroids | SFEBES2009
Reisch N
, Krone N
, Hughes B A
, Vassiliadi D A
, Flade L
, Bidlingmaier M
, Shackleton C H L
, Stewart P M
, Arlt W
Glucocorticoid treatment in congenital adrenal hyperplasia (CAH) is a continuous challenge, with even the experienced clinician struggling to strike the right balance between glucocorticoid over- and undertreatment. There is no consensus on monitoring of glucocorticoid therapy in adults with CAH. Some recommend a serum 17-hydroxyprogesterone (17OHP) target range of 1236 nmol/l prior to glucocorticoid morning dose. Here we investigated the value of serum and urinary stero...